Cytomx Therapeutics Inc (CTMX)

08:54 AM

CytomX Therapeutics Inc’s Shares Reel: -10.73% Quarterly Revenue Decline Amid 60.07M Market Cap - investchronicle.com

08:54 AM

Apr 15, 2025

CytomX Therapeutics (NASDAQ:CTMX) Now Covered by Piper Sandler - Defense World

Apr 15, 2025

Apr 15, 2025

CytomX Therapeutics (NASDAQ:CTMX) Coverage Initiated by Analysts at StockNews.com - Defense World

Apr 15, 2025

Apr 14, 2025

Piper Sandler sets CytomX stock target at $2.50, rates Overweight By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 14, 2025

CytomX Therapeutics (CTMX) Stock Poised for Growth Amid Clinical - GuruFocus

Apr 14, 2025

Apr 14, 2025

Piper Sandler Reaffirms Their Buy Rating on CytomX Therapeutics (CTMX) - The Globe and Mail

Apr 14, 2025

Apr 14, 2025

Piper Sandler sets CytomX stock target at $2.50, rates Overweight - Investing.com

Apr 14, 2025

Apr 12, 2025

New Outlook On CytomX Therapeutics Inc - stocksregister.com

Apr 12, 2025

Apr 12, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares Acquired by Prudential Financial Inc. - Defense World

Apr 12, 2025

Apr 09, 2025

CytomX Therapeutics Inc (NASDAQ: CTMX) 5.47% Incline Turns Investors Away - stocksregister.com

Apr 09, 2025

Apr 05, 2025

Revenues Working Against CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Share Price Following 26% Dive - simplywall.st

Apr 05, 2025

Apr 03, 2025

CytomX stock hits 52-week low at $0.56 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

CytomX stock hits 52-week low at $0.56 amid market challenges - Investing.com

Apr 03, 2025

Apr 02, 2025

Analysts Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Target Price at $5.02 - Defense World

Apr 02, 2025

Apr 01, 2025

Financial Metrics Check: CytomX Therapeutics Inc (CTMX)’s Ratios for Trailing Twelve Months - DWinneX

Apr 01, 2025

Apr 01, 2025

CytomX Therapeutics (NASDAQ:CTMX) Downgraded by StockNews.com to Hold - Defense World

Apr 01, 2025

Apr 01, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares Sold by Virtu Financial LLC - Defense World

Apr 01, 2025

Apr 01, 2025

StockNews.com Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Hold - The AM Reporter

Apr 01, 2025

Mar 26, 2025

CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability - MSN

Mar 26, 2025

Mar 23, 2025

CytomX Therapeutics (CTMX) Upgraded to Strong Buy: Here's What You Should Know - MSN

Mar 23, 2025

Mar 21, 2025

CytomX therapeutics CFO Christopher Ogden sells $5,122 in stock - Investing.com India

Mar 21, 2025

Mar 21, 2025

CytomX therapeutics general counsel sells $6,111 in stock - Investing.com India

Mar 21, 2025

Mar 21, 2025

CytomX Therapeutics CMO Yu-Waye Chu sells shares for $2,410 By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 20, 2025

Top Executives Cash Out: CytomX Therapeutics Stock Transactions Unveiled! - TipRanks

Mar 20, 2025

Mar 20, 2025

CytomX therapeutics CFO Christopher Ogden sells $5,122 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

CytomX Therapeutics CMO Yu-Waye Chu sells shares for $2,410 - Investing.com India

Mar 20, 2025

Mar 20, 2025

CytomX Therapeutics CEO sells $22,555 in stock By Investing.com - Investing.com South Africa

Mar 20, 2025

Mar 20, 2025

CytomX Therapeutics SVP Marcia Belvin sells $11,687 in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

CytomX Therapeutics SVP Marcia Belvin sells $11,687 in stock By Investing.com - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

CytomX Therapeutics CEO sells $22,555 in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

CytomX Therapeutics Executives Sell Shares for Tax Obligations - TradingView

Mar 20, 2025

Mar 20, 2025

CytomX therapeutics general counsel sells $6,111 in stock By Investing.com - Investing.com UK

Mar 20, 2025

Mar 13, 2025

CytomX Therapeutics’s SWOT analysis: biotech firm’s stock faces pivotal year By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

CytomX at Barclays Healthcare: Probody Platform Progress By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

CytomX at Barclays Healthcare: Probody Platform Progress - Investing.com India

Mar 12, 2025

Mar 12, 2025

CytomX Therapeutics’s SWOT analysis: biotech firm’s stock faces pivotal year - Investing.com India

Mar 12, 2025

Mar 11, 2025

Are CytomX Therapeutics Inc (CTMX) shares a good deal now? - US Post News

Mar 11, 2025

Mar 11, 2025

CytomX Therapeutics (NASDAQ:CTMX) Upgraded by StockNews.com to “Buy” Rating - Defense World

Mar 11, 2025

Mar 10, 2025

What Are You Thinking About Investing In CytomX Therapeutics Inc (NASDAQ: CTMX) Stock? - stocksregister.com

Mar 10, 2025

Mar 10, 2025

CytomX Therapeutics’ (CTMX) Outperform Rating Reiterated at Wedbush - Defense World

Mar 10, 2025

Mar 10, 2025

Earnings call transcript: CytomX Therapeutics Q4 2024 reports strong revenue - Investing.com India

Mar 10, 2025

Mar 10, 2025

CytomX Therapeutics’ (CTMX) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Mar 10, 2025

Mar 10, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of “Moderate Buy” by Brokerages - Armenian Reporter

Mar 10, 2025

Mar 08, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 08, 2025